Financial Solutions Advisory Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$507K Sell
20,889
-6,542
-24% -$171K 0.06% 109
2026
Q1
$770K Buy
+27,431
New +$730K 0.11% 78

Other funds holding PFE

Financial Solutions Advisory Group's PFE Position: Q2 2026 in Review

Financial Solutions Advisory Group reduced its Pfizer (PFE) stake by 24% in Q2 2026, selling an estimated $171K and leaving 20,889 shares worth $507K. The position accounts for 0.06% of the portfolio, ranked #109.

Financial Solutions Advisory Group first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $770K in Q1 2026. 799 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Financial Solutions Advisory Group held 20,889 shares of Pfizer worth $507K as of Q2 2026.
  • Financial Solutions Advisory Group sold 6,542 Pfizer shares in Q2 2026, an estimated $171K.
  • Pfizer made up 0.06% of Financial Solutions Advisory Group's portfolio in Q2 2026, its #109 holding.
  • Financial Solutions Advisory Group first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Financial Solutions Advisory Group's Pfizer position peaked at $770K in Q1 2026.
  • 799 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Financial Solutions Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.